CNMD - CONMED Corporation

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 53.06B
Enterprise value 33.85B
Trailing P/E 107.36
Forward P/E 135.64
PEG ratio (5-yr expected) 12.37
Price/sales (ttm)3.29
Price/book (mrq)4.37
Enterprise value/revenue 34.13
Enterprise value/EBITDA 623.68

Trading information

Stock price history

Beta (5Y monthly) 0.51
52-week change 359.47%
S&P500 52-week change 325.78%
52-week high 3116.81
52-week low 366.90
50-day moving average 3110.65
200-day moving average 3102.08

Share statistics

Avg vol (3-month) 3259.08k
Avg vol (10-day) 3255.74k
Shares outstanding 528.38M
Float 27.69M
% held by insiders 12.57%
% held by institutions 1104.36%
Shares short (30 Dec 2019) 41.02M
Short ratio (30 Dec 2019) 44.78
Short % of float (30 Dec 2019) 44.32%
Short % of shares outstanding (30 Dec 2019) 43.61%
Shares short (prior month 28 Nov 2019) 4971.72k

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 40.74%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 30.74%
5-year average dividend yield 41.45
Payout ratio 479.21%
Dividend date 306 Jan 2020
Ex-dividend date 411 Dec 2019
Last split factor 23:2
Last split date 309 Sep 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2018
Most-recent quarter (mrq)29 Sep 2019

Profitability

Profit margin 3.15%
Operating margin (ttm)9.80%

Management effectiveness

Return on assets (ttm)3.66%
Return on equity (ttm)4.33%

Income statement

Revenue (ttm)932.68M
Revenue per share (ttm)33.01
Quarterly revenue growth (yoy)15.50%
Gross profit (ttm)469.11M
EBITDA 162.54M
Net income avi to common (ttm)29.34M
Diluted EPS (ttm)1.01
Quarterly earnings growth (yoy)19.70%

Balance sheet

Total cash (mrq)30.07M
Total cash per share (mrq)1.06
Total debt (mrq)813.51M
Total debt/equity (mrq)116.06
Current ratio (mrq)2.48
Book value per share (mrq)24.70

Cash flow statement

Operating cash flow (ttm)78.96M
Levered free cash flow (ttm)63.16M